September wardrobe advice emphasizes practical, versatile pieces that can bridge summer and fall while helping shoppers avoid short-lived fashion trends and unnecessary purchases this season.
Fashion Month is entering a new season with rising entertainment, sports, and social-media figures positioned to influence front-row visibility and brand partnerships worldwide this year.
Houzz designers say warmer colors, layered textures, vintage pieces, natural materials, and wellness features are increasingly reshaping American home interiors for the fall season ahead.
Back-to-school shoppers are spreading purchases across the season and prioritizing deals as inflation, seasonal promotions, and household budgets reshape retail decisions for U.S. families nationwide.
American Airlines is expanding premium seating on long-haul aircraft, reflecting stronger demand for upscale travel while reducing space for standard economy passengers across international routes.
AAA says Labor Day travelers are choosing major U.S. cities, national parks, cruises, and European destinations while airfare prices remain uneven across routes this year.
Travel leaders are meeting with the Trump administration as international visits to the United States decline, raising questions about visas, costs, and tourism competitiveness nationwide.
A healthcare cyberattack exposed records linked to more than 1,400 U.S. patients, underscoring growing cybersecurity risks across the medical sector and healthcare supply chain nationwide.
The FDA is preparing to review GRAIL’s Galleri multi-cancer blood test, a technology designed to detect signals from many cancers through one blood sample soon.
FDA expanded Mounjaro’s approved use to reduce cardiovascular risk in certain adults with type 2 diabetes, broadening its role beyond glucose control and weight management.
FDA is seeking public feedback on regulating generative AI-enabled medical devices while balancing innovation, clinical evidence, cybersecurity, and patient safety for doctors and patients nationwide.
FDA approved the first oral drug specifically indicated for adult dermatomyositis, giving patients with the rare inflammatory disease a new treatment option nationwide for patients.
